Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study
Titel:
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study
Auteur:
Rousseau, Benoit Boukerma, Arezki K. Henriques, Julie Cohen, Romain Lucidarme, Olivier Borg, Christophe Tournigand, Christophe Kim, Stefano Bachet, Jean-Baptiste Mazard, Thibault Louvet, Christophe Chibaudel, Benoist Vernerey, Dewi Andre, Thierry Hulin, Anne